The U.S. FDA has informed Novo Nordisk that a three-month extension period was required in order to complete its regulatory review of the new drug applications (NDA) for the ultra-long-acting insulins degludec and insulin degludec/insulin aspart...
Since being diagnosed with type 1 diabetes I’ve become much more in tune with my body. This didn’t happen all at once but as the years have gone by I’ve…
Symphony is a needle free, wireless, transdermal continuous glucose monitoring system designed to provide accurate, real-time continuous blood glucose data...
We're big fans of Casual Kitchen, a food blog focused on food philosophy, money-saving ideas and easy and inexpensive recipes. So we're very glad its author, Daniel Koontz...